[
    [
        {
            "time": "",
            "original_text": "安图生物(603658)：3Q21净利润高增长 现金流改善",
            "features": {
                "keywords": [
                    "安图生物",
                    "3Q21",
                    "净利润",
                    "高增长",
                    "现金流",
                    "改善"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物(603658)：3Q21净利润高增长 现金流改善",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "安图生物(603658)：21Q3业绩符合预期 各项业务恢复较快增长",
            "features": {
                "keywords": [
                    "安图生物",
                    "21Q3",
                    "业绩",
                    "符合预期",
                    "业务",
                    "恢复",
                    "较快增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物(603658)：21Q3业绩符合预期 各项业务恢复较快增长",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]